Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for regression symptoms and impaired activities of daily living in Down syndrome
jRCT2080222131Phase 2
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Down syndrome comparing Donepezil with Placebo / Donepezil (2 arms).
02
Drugs
donepezil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on jRCT2080222131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222131.